PATENT CLAIM ANALYSIS

Application Number: 16130217
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-07
Patent Classification: ["514", "375000"]

Abstract:
Powder oral suspension formulations of antibacterial compounds are described herein. In addition, reconstitutable powders of antibacterial compounds and oral suspension formulations thereof are described herein.

Claim (Index 14):
A pharmaceutical formulation comprising the composition of  claim 1 .

Metadata:
- Claim Count in Document: 31.0
- Percentile: 97.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14387643', '15622544', '15622388', '15861017', '12656936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5920037664251308
- 35 USC 102 Novelty (BERT): 0.4793695413232148
- Combined Prediction Score: 0.5807403439149391
- Mean Citation Score: 169.35233
- Max Citation Score: 187.27219
- Similarity Product: 150.91686051210223

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test